These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer].
    Author: Jiang Z, Hua H.
    Journal: Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1310-3. PubMed ID: 19673399.
    Abstract:
    The occurrence of liver cancer is a multi-phase and multi-factor process, while Chinese medicine used for antitumor is all-round with multiple approaches. This summary is a literature review which elaborates the prevention and treatment of Chinese medicine to the molecular mechanism of liver cancer in eight aspects, such as inhibiting the proliferation of hepatoma cell, inducing their differentiation, affecting the activity of telomerase, resisting the invasion and metastasis of hepatoma cell, inhibiting the formation of tumor vessel, adjusting the immunity function, and reversing the multidrug resistance, etc.
    [Abstract] [Full Text] [Related] [New Search]